Miami, Florida(Hexa PR Wire–November 27, 2025)–Dr. Will Soliman, pharmaceutical industry futurist, former Big Pharma executive, and founder of the Accreditation Council for Medical Affairs (ACMA), joined The Michael Peres Podcast to trace an unlikely path from food scientist at Mars Chocolate to leading the global standard-setter for pharma professionals. He discussed launching White Manna Capital Partners, advising Congress on professional standards, and why AI-driven discovery, safety, and engagement are about to transform medicine faster than most expect.
About Dr. Will Soliman
Dr. William Soliman is the Founder & CEO of the ACMA, the leading accreditation and certification body for life-sciences and prior-authorization professionals. He is also the Founder & CEO of White Manna Capital Partners, a biotech- and pharma-focused hedge fund. A former senior executive at Merck, AbbVie, and Gilead, he has testified before the U.S. House Health Subcommittee and is frequently featured across major media. Dr. Soliman holds a PhD from Columbia University and a BA from NYU.
About Michael Peres
Michael Peres is a software engineer, entrepreneur, and journalist who hosts The Michael Peres Podcast—short, insight-dense conversations with operators and thinkers across tech, science, and culture.
About The Michael Peres Podcast
The show spotlights practitioners with hard-won lessons, prioritizing practical frameworks listeners can apply immediately.
Contact Information
William Soliman: Email
This article was originally published at: https://hexaprwire.com/dr-will-soliman-joins-the-michael-peres-podcast-to-discuss-building-acma-and-raising-standards/